The White House said Tuesday it has the “utmost confidence” in Food and Drug Administration (FDA) Commissioner Mary Makary and dismissed calls for his ouster from prominent anti-abortion groups as “uninformed attacks.” Leaders of the anti-abortion groups SBA Pro-Life America and Live Action earli... Read more
The Hill - Dec 09
Three Republican-led states have challenged the Food and Drug Administration’s (FDA) approval of a generic form of the abortion pill mifepristone earlier this year, arguing the agency’s decision had ignored the “dangerous effects of mifepristone on pregnant women and girls.” The attorney generals... Read more
The Hill - Nov 21
The Food and Drug Administration has approved a generic version of the abortion pill mifepristone, expanding its supply at a time when the Trump administration is under pressure from abortion opponents to sharply restrict access to abortion pills. Read more
Buffalonews - Oct 04
Click in for more news from The Hill {beacon} Health Care Health Care The Big Story Fallout persists from abortion pill approval The Food and Drug Administration is facing new pressure from lawmakers and anti-abortion groups, who are feeling betrayed after the agency approved a second generic ver... Read more
The Hill - Oct 04
Biotech news updates you need to read, brought to you by The Readout. Read more
Stat - Oct 03
The FDA approved another generic version of the mifepristone abortion pill, a regulatory formality that triggered pushback from anti-abortion groups Read more
Stat - Oct 03
Abortion rights supporters hail win for evidence-backed medicine as Evita Solutions’ generic version of mifepristone given approvalIn a move that has left anti-abortion advocates reeling, the US Food and Drug Administration (FDA) quietly approved a request to manufacture a new abortion pill earli... Read more
The Guardian - Oct 02
The drug will now be produced by Evita Solutions LLC, which describes its mission as being to ‘normalize abortion’ Read more
The Independent - Oct 02
The agency's decision has drawn conservative criticism. Read more
Politico - Oct 02
